A Human Ovarian Carcinoma Murine Xenograft Model Useful for Preclinical Trials

This publication has 12 references indexed in Scilit:

• Primary Ovarian Cancer Cultures are Resistant to Fas-Mediated Apoptosis
  Gynecologic Oncology, 1999
• Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer
  Cancer Chemotherapy and Pharmacology, 1999
• Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: Implications for ovarian cancer screening
  American Journal of Obstetrics and Gynecology, 1999
• Characterization of Human Ovarian Carcinomas in a SCID Mouse Model
  Gynecologic Oncology, 1999
• Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
  Nature Medicine, 1997
• Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer
  Human Gene Therapy, 1994
• Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen
  Biochemical Pharmacology, 1992
• Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel
  JNCI Journal of the National Cancer Institute, 1991
• Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy
  International Journal of Cancer, 1989
• Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia
  Science, 1985